Clinical trials in Stockholm – page 14

250 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Stockholm at a glance

250

clinical trials

Research sites8

Quick filters

250 trials in Stockholm

Open in trial search

Chronic obstructive pulmonary disease

Not recruiting

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Astegolimab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Inclisiran
Sponsor:Novartis Pharma AG

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Chronic rhinosinusitis with nasal polyps

Not recruiting

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Itepekimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Follicular lymphoma

Not recruiting

Phase II Study of ME-401, Rituximab and Bendamustine as First‑Line Treatment for High‑Risk and Low‑Risk Follicular Lymphoma Patients

Registered drugNo placebo

Phase II Study of ME-401, Rituximab and Bendamustine as First‑Line Treatment for High‑Risk and Low‑Risk Follicular Lymphoma Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bendamustine
Sponsor:Karolinska University Hospital

Contact Research Centre

Gastric cancer+6

Not recruiting

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

InvestigationalNo placebo

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cldn6 Car-T
Sponsor:BioNTech Cell & Gene Therapies GmbH

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Salbutamol
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Triple negative breast cancer

Not recruiting

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:AstraZeneca AB

Contact Research Centre

Type IIa hyperlipidaemia

Not recruiting

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational

Sweden

Participants:18–64 years · 65+ years
Sponsor:AstraZeneca AB

Contact Research Centre

Herpes zoster

Not recruiting

Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

Registered drugNo placebo

Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Recombinant Varicella Zoster Virus Glycoprotein E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Stockholm

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.

Prostate Cancer Therapies
Breast Cancer Treatments
Colorectal Cancer Studies

Innovative research comparing various treatment protocols and investigating survival outcomes.

02 Infectious Diseases

Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.

Vaccine Development
Viral Disease Prevention
Immunization Studies

Focus on prevention and immune response in various age groups.

03 Cardiovascular Health

Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.

Cardiac Arrest Management
Heart Failure Prevention
Cardiomyopathy Treatment

Emphasis on improving patient outcomes and testing novel drug combinations.

04 Neurological Disorders

Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.

Disease Modification
Symptom Management
Treatment Efficacy

Studies evaluating both novel and existing therapeutic approaches.

05 Metabolic Conditions

Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.

Weight Management
Diabetes Control
Metabolic Health

Focus on lifestyle interventions combined with pharmaceutical approaches.

Back to Sweden All countries